CURRENT PHARMACEUTICAL ANALYSIS, cilt.17, sa.3, ss.409-420, 2021 (SCI-Expanded)
Background: The Human Immunodeficiency Virus (HIV) has now been established as the causative agent of the Acquired Immunodeficiency Syndrome (AIDS) and exactly 25 antiretroviral drugs have been formally approved for clinical use in the treatment of AIDS. The life quality and duration of HIV-positive patients have increased with the usage of antiretroviral drugs in the treatment of AIDS. Nucleoside Reverse Transcriptase Inhibitors (NRTIs) arc one of the subgroups of antiretroviral.